A Phase 2, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Coadministered Ceftaroline Fosamil and NXL104 Versus Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infection.

Trial Profile

A Phase 2, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Coadministered Ceftaroline Fosamil and NXL104 Versus Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infection.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2016

At a glance

  • Drugs Avibactam/ceftaroline fosamil (Primary) ; Doripenem
  • Indications Bacterial infections; Urinary tract infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Cerexa; Forest Laboratories
  • Most Recent Events

    • 16 Mar 2012 Actual patient number (217) and additional trial locations added as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Planned End Date changed from 1 Jun 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top